Dublin, Ireland – November 4, 2025: Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-powered healthcare and specialty pharma, today announced that it will participate in the following upcoming healthcare investor conferences:
- Jefferies Global Healthcare Conference in London, November 19, 2025: Giovanni Di Napoli, Chief Executive Officer, will take part in a fireside chat at 12:30 pm, GMT, and will be joined by Svetlana Sigalova, Chief Financial Officer, for one-on-one meetings with investors.
- 2025 Berenberg European Conference in Windsor, UK, December 3, 2025: Svetlana Sigalova, Chief Financial Officer will be available for one-on-one meetings with investors.
If you would like to arrange an individual meeting with Cosmo’s representatives, please contact investor.relations@cosmohc.com.
The slide decks of the relevant presentations will be available after the respective event for download on the Company’s website via www.cosmopharma.com/investors/events-and-presentations.
About Cosmo
Cosmo is a life sciences company focused on MedTech AI, dermatology, gastrointestinal diseases, and contract development and manufacturing (CDMO). We design, develop, and manufacture advanced solutions that address critical medical needs and raise the standard of care. Our technologies are trusted by leading global pharmaceutical and MedTech companies and reach patients and healthcare providers around the world. Guided by our purpose – Building Health Confidence – our mission is to empower patients, healthcare professionals, and partners by innovating at the intersection of science and technology. Founded in 1997, Cosmo is headquartered in Dublin, Ireland, with offices in San Diego (USA), and in Lainate, Rome, and Catania (Italy). For more information, visit www.cosmohealthconfidence.com.